-+ 0.00%
-+ 0.00%
-+ 0.00%

ALTERITY THERAPEUTICS RECEIVES FDA END-OF-PHASE 2 MEETING MINUTES CONFIRMING REGISTRATIONAL PATHWAY FOR ATH434 IN MULTIPLE SYSTEM ATROPHY

Reuters·07/07/2026 11:05:00

Please log in to view news